Fund profile
Hippocrates VC
United States
Leading
About
Hippocrates VC is a physician-backed venture capital firm specializing in digital health startups. With a focus on impact-driven investments, they aim to transform healthcare delivery through innovative technologies. Notable portfolio companies include Fruit Street, which provides diabetes prevention via telehealth, and Avive AED, developing life-saving tools for sudden cardiac arrest. Smiley Scope, another investment, uses VR to improve patient outcomes. Their geographic focus is primarily the U.S., and they target startups that can scale globally. Hippocrates seeks early-stage ventures, often leading rounds with an average check size of $500k to $2M. They prefer companies at the intersection of healthcare and technology, especially those offering digital therapeutics or telemedicine solutions. The fund is led by Laurence Girard, a healthcare entrepreneur who previously raised over $40M for his ventures. Under his leadership, Hippocrates maintains a strong network of physician investors, creating a unique ecosystem for healthcare innovation. To approach the fund, startups are encouraged to demonstrate clear clinical impacts and a solid path to commercialization, especially within regulated healthcare markets.
Details
Highlights
$3.4M
Historical average check
$3.4M
Historical max check
December 2018
Last investment date
1
Investments
Healthtech & Wellness
Showing 0 lists
Contacts
Website
hippocratesvc.comSocial
Lists that include this fund